NYSE:UI
NYSE:UICommunications

Does Ubiquiti’s Audit Committee Shortfall Reveal Deeper Governance Risks for Investors in UI?

Ubiquiti Inc. reported that longtime director Ronald A. Sege, who joined the board in 2012 and most recently chaired its nominating and corporate governance committee while serving on the audit and compensation committees, passed away on November 30, 2025, leaving his Class II board seat temporarily vacant. His passing reduced the audit committee to two independent directors, putting Ubiquiti out of compliance with New York Stock Exchange rules that require three independent audit committee...
NYSE:BIP
NYSE:BIPIntegrated Utilities

Should Brookfield Infrastructure Partners’ Expanded Buybacks and Preferred Redemption Strategy Require Action From BIP Investors?

Brookfield Infrastructure Partners L.P. recently renewed its normal course issuer bids, gaining TSX approval to repurchase up to 23,062,017 LP Units, significant portions of several preferred unit series, and up to 10,594,212 Brookfield Infrastructure Corporation exchangeable shares through December 1, 2026, while also moving to redeem all outstanding Series 3 preferred units at C$25.00 each. This combination of renewed buyback capacity and the planned cash redemption of an entire preferred...
NasdaqGS:LEGN
NasdaqGS:LEGNBiotechs

CAR-T Durability And Off-the-Shelf Progress Could Be A Game Changer For Legend Biotech (LEGN)

Legend Biotech recently reported long-term clinical results showing a median progression-free survival of 50.4 months for CARVYKTI in heavily pretreated multiple myeloma patients, alongside early Phase 1 data for its allogeneic CAR-T candidate LUCAR-G39D that delivered a 75% overall response rate with manageable safety in relapsed or refractory B-cell non-Hodgkin lymphoma. These past data releases highlight how earlier use of CARVYKTI and progress in off-the-shelf CAR-T technology could...
NasdaqGS:IRBT
NasdaqGS:IRBTConsumer Durables

iRobot (IRBT) Valuation Check After Trump’s Potential Robotics Support Sparks Speculation

iRobot (IRBT) just swung back into the spotlight after reports that the Trump administration is weighing an executive order to support the domestic robotics industry, sparking a sharp rally and fresh questions about its long term prospects. See our latest analysis for iRobot. The speculation around federal support has lit a fire under iRobot, with a 133.54% 7 day share price return and a 67.73% 30 day share price return, yet the 1 year total shareholder return of minus 58.72% shows that long...
NYSE:ENS
NYSE:ENSElectrical

EnerSys (ENS) valuation after multiple earnings beats and stronger AI data center growth outlook

EnerSys (ENS) is back on investors radar after another earnings beat and a higher full year outlook, with the market starting to tie its industrial batteries more directly to the AI data center buildout. See our latest analysis for EnerSys. The latest beat and guidance hike have capped a powerful run, with EnerSys sitting around $147.65 after a roughly 60 percent year to date share price return and a triple digit three year total shareholder return that signal momentum is still building. If...
NYSE:XPEV
NYSE:XPEVAuto

XPeng (NYSE:XPEV) Valuation Check After November Delivery Slowdown and Strong Year‑to‑Date Growth

XPeng (XPEV) just posted fresh November delivery numbers, and they are a bit of a mixed bag that still leans encouraging for long term holders watching the company’s execution closely. See our latest analysis for XPeng. That mix of softer monthly deliveries but powerful year to date growth seems to mirror the stock action, with a recent 30 day share price return of minus 10.79 percent but a much stronger year to date share price return of 73.16 percent, and a 1 year total shareholder return...
NasdaqGS:QLYS
NasdaqGS:QLYSSoftware

Qualys (QLYS) Valuation Check After Strong Q3 Beat and Raised Full-Year Guidance

Qualys (QLYS) just delivered a stronger than expected third quarter, lifting revenue, widening margins, and raising full year guidance. That upgraded outlook is what has investors reassessing the stock. See our latest analysis for Qualys. Even with today’s earnings bump, Qualys’ share price at about $146 still reflects a mixed picture, with a modest year to date share price return but a slightly negative 1 year total shareholder return. This suggests that near term momentum is rebuilding...
NYSE:VIK
NYSE:VIKHospitality

Viking Holdings (VIK): Evaluating Valuation After Q3 Earnings Beat, Record EBITDA and Strong 2025–2026 Bookings

Viking Holdings (VIK) just delivered a big third quarter earnings beat, with record Adjusted EBITDA and stronger than expected bookings into 2025 and 2026, and Wall Street is taking notice. See our latest analysis for Viking Holdings. The upbeat Q3 surprise fits neatly into a strong run, with a roughly 53% year to date share price return and 44% one year total shareholder return suggesting momentum is still building around Viking’s growth story. If Viking’s surge has you thinking more broadly...
NYSE:EFC
NYSE:EFCMortgage REITs

How Investors Are Reacting To Ellington Financial (EFC) Reaffirming Dividends After Strong Q3 And Debt Raise

Ellington Financial Inc. announced that its Board of Directors has declared monthly and quarterly dividends on its common and preferred shares, including a US$0.13 common dividend payable on January 30, 2026, and Series A–D preferred dividends ranging from US$0.390625 to US$0.593907 per share. These dividend affirmations, coming after a strong third quarter supported by robust net income, an expanded credit portfolio, and a US$400.00 million unsecured note issuance, highlight the company’s...
NasdaqGS:BLKB
NasdaqGS:BLKBSoftware

A look at Blackbaud’s (BLKB) valuation following its new Anthropic AI partnership and ‘Agents for Good’ launch

Blackbaud (BLKB) just gave investors a lot to chew on, pairing a strategic AI partnership with Anthropic and its new Agents for Good with a bigger buyback authorization, all aimed squarely at long term growth. See our latest analysis for Blackbaud. That backdrop helps explain why the 7 day share price return of 12.97 percent and 30 day share price return of 11.04 percent stand in contrast to a weaker year to date share price return of 13.61 percent and a 1 year total shareholder return of...
NYSE:GL
NYSE:GLInsurance

Globe Life (GL): Assessing Whether Recent Gains Still Leave Upside in the Valuation

Globe Life (GL) has been quietly grinding higher this year, and with the stock up roughly 26% over the past year, investors are asking whether the current valuation still leaves meaningful upside. See our latest analysis for Globe Life. That 26.5% one year total shareholder return reflects more than just a good run; it comes after a solid year to date share price gain as investors warm to Globe Life's steady earnings profile despite some recent share price consolidation around $131.37. If...
NasdaqGS:DXCM
NasdaqGS:DXCMMedical Equipment

How New CGM Lawsuits And Dexcom Academy At DexCom (DXCM) Have Changed Its Investment Story

In late November and early December 2025, DexCom faced new securities class action lawsuits over alleged unauthorized design changes to its G6 and G7 CGM systems, while also launching Dexcom Academy, a personalized education platform for healthcare professionals across several EMEA markets. This combination of legal scrutiny around product safety claims and investment in clinician training tools highlights the tension between regulatory risk and efforts to strengthen long-term adoption of...
NYSE:AEE
NYSE:AEEIntegrated Utilities

Assessing Ameren (AEE) Valuation After Its Recent Pullback and Ongoing Grid Modernization Plans

Ameren (AEE) has quietly outperformed many utilities this year, and the recent pullback after its latest move has some investors wondering whether this is a chance to add a steady dividend name. See our latest analysis for Ameren. At around $99.86, Ameren’s recent 7 day share price return of minus 6.10 percent comes after a solid year to date share price gain of 12.21 percent. Its 5 year total shareholder return of 48.19 percent suggests longer term, compounding gains remain intact even as...
NYSE:ES
NYSE:ESElectric Utilities

Eversource Energy (ES): Reassessing Valuation After Recent Share Price Pullback

Eversource Energy (ES) has quietly slipped about 9% over the past month, even as its year to date return remains firmly positive. That pullback is drawing fresh attention to what investors are actually paying for this regulated utility’s earnings power. See our latest analysis for Eversource Energy. That recent 1 month share price return of negative 8.63% comes after a solid 16.39% year to date share price gain. This suggests momentum has cooled even though the 1 year total shareholder return...
NYSE:MTB
NYSE:MTBBanks

Is M&T Bank (MTB) Undervalued After Its Recent One‑Month Share Price Gain?

M&T Bank (MTB) has quietly outpaced the broader regional bank group over the past month, climbing about 5% while still sitting roughly 5% below where it traded a year ago. See our latest analysis for M&T Bank. At around $195.11 per share, M&T’s recent 1 month share price return of roughly 5% hints that sentiment is improving again, even though its 1 year total shareholder return is still slightly negative while the 5 year total shareholder return remains solid. If this kind of steady banking...
NasdaqGS:CFLT
NasdaqGS:CFLTSoftware

Evaluating Confluent’s (CFLT) Valuation After Strong Q3 Results and Raised AI‑Driven Growth Guidance

Confluent (CFLT) just delivered an upbeat third quarter, with revenue climbing around 19% and subscriptions accelerating across Confluent Cloud and Platform. This prompted management to lift full year guidance and lean harder into AI driven data streaming. See our latest analysis for Confluent. Despite the upbeat quarter, Confluent’s share price return over the past year is still negative. The 90 day share price return of 14.33% suggests momentum is tentatively rebuilding as investors...
NasdaqGS:OKTA
NasdaqGS:OKTAIT

Why Okta (OKTA) Is Up 6.9% After Raising Guidance And Highlighting AI Security Momentum

In the past week, Okta reported third-quarter fiscal 2025 results with revenue of US$742 million and net income of US$43 million, showing higher earnings per share year-on-year and raising full-year fiscal 2026 revenue guidance to about US$2.91 billion. The quarter also highlighted traction in newer areas such as AI-focused security products and expanding large customer contracts, which supported stronger profitability and an uplift in remaining performance obligations versus analyst...
NYSE:MCK
NYSE:MCKHealthcare

Is McKesson’s (MCK) ORLYNVAH Distribution Deal a Small Step or a Bigger Strategy Signal?

In late November 2025, Iterum Therapeutics announced that its oral antibiotic ORLYNVAH became available through McKesson’s specialty distribution channel, enabling certain physicians to order the drug directly in line with their practice preferences. This addition highlights how McKesson’s growing specialty distribution capabilities complement its broader shift toward higher-growth areas like oncology, specialty drugs, and tech-enabled services, which underpin its repeatedly raised fiscal...
NYSE:SEI
NYSE:SEIEnergy Services

Solaris Energy Infrastructure (SEI): Reassessing Valuation After Bullish Analyst Coverage on Distributed Power Pivot

Morgan Stanley and Piper Sandler have both leaned in on Solaris Energy Infrastructure (SEI) after its pivot into distributed power, spotlighting the Mobile Energy Rentals acquisition as a key driver of its fast growing turbine business. See our latest analysis for Solaris Energy Infrastructure. The bullish commentary has landed on a stock that already has serious momentum, with a roughly 88 percent year to date share price return and a three year total shareholder return above 560 percent...
NYSE:ELV
NYSE:ELVHealthcare

Will Elevance Health’s Expanded AI Virtual Assistant Rollout Reshape Elevance Health's (ELV) Narrative

Earlier this week, Elevance Health expanded access to its AI-powered Virtual Assistant across the Sydney Health app and affiliated plan websites, extending the tool to roughly 22 million commercial members to help them understand benefits, estimate costs, and find in-network care in English and Spanish. The rollout, supported by early data showing high member success in getting answers, aligns with investors’ focus on Elevance’s technology-driven efficiency push and recent double-digit...
NasdaqGS:PFBC
NasdaqGS:PFBCBanks

Shrinking Net Interest Margin And EPS At Preferred Bank Might Change The Case For Investing In PFBC

Recent analysis of Preferred Bank highlighted that over the last few years its net interest income has grown more slowly than peers, while its net interest margin shrank by 74 basis points and earnings per share fell by 4.7% annually, pointing to pressure on profitability even before today’s date of 7 Dec 2025. These trends suggest that Preferred Bank’s loan book and funding mix may be facing tougher competition and weaker economics than many comparable banks, raising questions about the...
NasdaqGS:ADSK
NasdaqGS:ADSKSoftware

How Strong Q3 Results, Buybacks and Higher Guidance At Autodesk (ADSK) Has Changed Its Investment Story

Autodesk reported past third-quarter fiscal 2026 results with revenue of US$1,853 million and net income of US$343 million, alongside higher GAAP EPS, and also completed a multi-year buyback totaling about 8.02 million shares for US$2.19 billion under its 2022 authorization. The company raised its full-year fiscal 2026 guidance, now expecting revenue of US$7,150 million to US$7,165 million and GAAP EPS of US$5.16 to US$5.33, underscoring management’s confidence in ongoing business...
NYSE:CVNA
NYSE:CVNASpecialty Retail

Carvana (CVNA): Assessing Valuation After S&P 500 Inclusion and Record Profitability Turnaround

Carvana (CVNA) is back in the spotlight after being tapped to join the S&P 500, a milestone that caps its turnaround from a distressed pandemic play to a profitable, large cap e commerce auto retailer. See our latest analysis for Carvana. The S&P 500 nod caps a wild run, with Carvana’s share price returning about 100% year to date and its three year total shareholder return above 7,800 percent as bullish upgrades, record results, and high profile endorsements fuel momentum. If Carvana’s surge...